Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: An observational study

Respirology

Volumn 18, Issue 8, 2013, Pages 1184-1190

  Anandam, Anil ^a   Patil, Monali ^a   Akinnusi, Morohunfolu ^a   Jaoude, Philippe ^a   El Solh, Ali A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

cardiovascular mortality; continuous positive airway pressure; obstructive sleep apnoea; oral appliance; outcome

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; APNEA HYPOPNEA INDEX; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FATALITY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MANDIBULAR ADVANCING DEVICE; NON INVASIVE SURGICAL DEVICE; OBSERVATIONAL STUDY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SUDDEN CARDIAC DEATH;

CARDIOVASCULAR MORTALITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; OBSTRUCTIVE SLEEP APNOEA; ORAL APPLIANCE; OUTCOME;

ADULT; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MANDIBULAR ADVANCEMENT; MIDDLE AGED; POLYSOMNOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84883519843     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12140     Document Type: Article

References (33)

1. Engleman HM, Martin SE, Kingshott RN, et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998; 53: 341-345.
2. Engleman HM, Kingshott RN, Wraith PK, et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am. J. Respir. Crit. Care Med. 1999; 159: 461-467.
3. Kohler M, Stoewhas AC, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2011; 184: 1192-1199.
4. Sanders MH, Montserrat JM, Farre R, et al. Positive pressure therapy: a perspective on evidence-based outcomes and methods of application. Proc. Am. Thorac. Soc. 2008; 5: 161-172.
5. Marin J, Carrizo S, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
6. Weaver TE, Grunstein RR,. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc. Am. Thora. Soc. 2008; 5: 173-178.
7. Ng A, Gotsopoulos H, Darendeliler AM, et al. Oral appliance therapy for obstructive sleep apnea. Treat. Respir. Med. 2005; 4: 409-422.
8. Ferguson KA, Cartwright R, Rogers R, et al. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006; 29: 244-262.
9. Randerath WJ, Verbraecken J, Andreas S, et al. Non-CPAP therapies in obstructive sleep apnoea. Eur. Respir. J. 2011; 37: 1000-1028.
10. Gindre L, Gagnadoux F, Meslier N, et al. Mandibular advancement for obstructive sleep apnea: dose effect on apnea, long-term use and tolerance. Respiration 2008; 76: 386-392.
11. Peled E, Yoffe N, Blumenfeld I, et al. Short and long-term usage of a dental device in sleep apnea syndrome. Laryngoscope 2009; 119: 585-588.
12. Marklund M, Franklin KA,. Long-term effects of mandibular repositioning appliances on symptoms of sleep apnoea. J. Sleep Res. 2007; 16: 414-420.
13. Andren A, Sjoquist M, Tegelberg A,. Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance-a three-year follow-up. J. Oral Rehabil. 2009; 36: 719-725.
14. Aarab G, Lobbezoo F, Heymans MW, et al. Long-term follow-up of a randomized controlled trial of oral appliance therapy in obstructive sleep apnea. Respiration 2011; 82: 162-168.
15. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the management of arterial hypertension. J. Hypertens. 2007; 25: 1751-1762.
16. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005; 28: 499-521.
17. Flemons W, Buysse D, Redline S, et al. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
18. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann. Intern. Med. 2012; 156: 115-122.
19. Martinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am. J. Respir. Crit. Care Med. 2009; 180: 36-41.
20. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127: 2076-2084.
21. He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9-14.
22. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008; 31: 1071-1078.
23. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
24. Mooe T, Franklin KA, Holmstrom K, et al. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am. J. Respir. Crit. Care Med. 2001; 164: 1910-1913.
25. Lam B, Sam K, Mok WY, et al. Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax 2007; 62: 354-359.
26. Gauthier L, Laberge L, Beaudry M, et al. Mandibular advancement appliances remain effective in lowering respiratory disturbance index for 2.5-4.5 years. Sleep Med. 2011; 12: 844-849.
27. Itzhaki S, Dorchin H, Clark G, et al. The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 2007; 131: 740-749.
28. Trzepizur W, Gagnadoux F, Abraham P, et al. Microvascular endothelial function in obstructive sleep apnea: impact of continuous positive airway pressure and mandibular advancement. Sleep Med. 2009; 10: 746-752.
29. Martinez-Garcia MA, Campos-Rodriguez F, Soler-Cataluna JJ, et al. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment. Eur. Respir. J. 2012; 39: 906-912.
30. Suzuki Y, Jain V, Park A, et al. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic. Biol. Med. 2006; 40: 1683-1692.
31. Lowe AA, Sjoholm TT, Ryan CF, et al. Treatment, airway and compliance effects of a titratable oral appliance. Sleep 2000; 23 (Suppl. 4): S172-178.
32. Gotsopoulos H, Chen C, Qian J, et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am. J. Respir. Crit. Care Med. 2002; 166: 743-748.
33. Randerath WJ, Heise M, Hinz R, et al. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest 2002; 122: 569-575.